TG Therapeutics TGTX 深 沪
等待开盘 11-02 09:30:00 美东时间
61.18
+3.100
+5.34%
华盛通- 最 高61.7599
- 今 开58.15
- 成交量 285.61万股
- 最 低 58.00
- 昨 收 58.08
- 总市值 93.65亿
- 52周最高 61.7599
- 市盈率 静 22.08
- 换手率 1.87%
- 52周最低 26.76
- 委 比 -30.92%
- 总股本 1.53亿
- 历史最高 61.7599
- 量 比 1.94
- 振 幅 6.47%
- 历史最低 0.9563
- 每 手 1
- 风险率 10.92%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多TG Therapeutics Inc.收涨1.7%，成交额5240.74万美元
10月29日，TG Therapeutics Inc.（TGTX）收涨1.7%，报57.4美元，成交额5240.74万美元，市值87.86亿美元。 行情数据 ...
10-29 04:56
TG Therapeutics Inc.收涨1.9%，成交额1.07亿美元
10月24日，TG Therapeutics Inc.（TGTX）收涨1.9%，报54.17美元，成交额1.07亿美元，市值82.92亿美元。 行情数据 • 开...
10-24 04:58
TG Therapeutics' Initial Data From Its Phase 1 Trial Of Azercabtagene Zapreleucel In Patients With Progressive Multiple Sclerosis Demonstrates 89% Of Evaluable Participants Had Stable Or Improved Disability Scores At Day 90
TG Therapeutics, Inc. (NASDAQ:TGTX), today announced initial results from the Company’s Phase 1 study evaluating azercabtagene zapreleucel (azer-cel), an investigational, allogeneic CD19-directed chimeric antigen receptor (CAR) T-cell therapy, in patients with progressive multiple sclerosis (MS). Th...
10-23 22:58
TG Therapeutics Inc.收跌3.62%，成交额9608.79万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 04:58
Most shorted stocks on Wall Street
As October begins, investors are keeping a close eye on heavily shorted stocks that could see heightened volatility. The latest mid- to mega-cap screen shows 39 stocks with short interest above 20% of...
10-05 21:35
Biotech ETF XBI Hits an Interest Rate Wall as 40+ Catalysts Approach
The biotech sector is heading into the third-quarter earnings season with a tug-of-war between higher interest rates and an unusually heavy pipeline of company-specific catalysts. The SPDR S&P Biotech ETF (NYSE:XBI) is up about 27% year to date, but has declined roughly 8.3% in the past 30 days. The...
09-26 04:19
TG Therapeutics to Participate in the Cantor Global Healthcare Conference
TG Therapeutics announced that CEO Michael S. Weiss will participate in the Cantor Global Healthcare Conference on September 9-11, 2026. A fireside chat is scheduled for September 9 at 11:30am ET, with a live webcast available on the company’s website. TG Therapeutics focuses on developing treatments for B-cell diseases and has FDA approval for BRIUMVI to treat multiple sclerosis.
09-03 11:30
Most shorted stocks on Wall Street
As September begins, investors are keeping a close eye on heavily shorted stocks that could see heightened volatility. The latest mid- to mega-cap screen shows 44 stocks with short interest above 20% ...
09-02 22:28
美股大行评级 | 美银上调微软目标价从500美元升至600美元；BlossomHill获小摩等多家大行首予买入评级
今日重点评级关注：BTIG：维持Kazia Therapeutics"买入"评级，目标价从34美元升至40美元；摩根大通：维持Annexon"超配"评级，目标价从10美元升至14美元
09-02 14:07
HC Wainwright & Co. Reiterates Buy on TG Therapeutics, Maintains $78 Price Target
HC Wainwright & Co. analyst Emily Bodnar reiterates TG Therapeutics (NASDAQ:TGTX) with a Buy and maintains $78 price target.
09-02 01:10
